- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
S
SCNI
Scinai Immunotherapeutics Ltd.
0.72
-0.04-5.26%After Hours: 0.7205 +0.0005 +0.07%19:31 02/20 EST
OPEN/PREV CLOSE0.7962/0.7600
TODAY RANGE0.7200-0.7962
VOL24.17K
MARKET CAP2.50M
52 WEEK RANGE0.6130-6.18
AVG VOL (3M)48.98K
% TURNOVER0.70%
TURNOVER--
P/E (TTM)0.0901
% RANGE10.03%
EPS(TTM)7.99
P/E(FORWARD)-0.3600
P/B0.1388
BVPS5.19
DIVIDEND--
P/S0.9326
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.24M
SHARES OUTSTANDING3.47M
NEXT EARNINGS--
FREE FLOAT3.11M
LOT SIZE1
EX-DATE05/21/2024
News
Press Releases
Financial Reports
Profile
Benzinga·01/14 12:05
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga·12/31/2025 12:06
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga·12/26/2025 12:05
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga·12/22/2025 12:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
TipRanks·12/03/2025 03:52
Scinai Immunotherapeutics Reports Growth and Pipeline Progress
TipRanks·12/02/2025 16:27
Scinai Immunotherapeutics Reports Nine-Month 2025 Results and Strategic Developments
PR Newswire·12/02/2025 13:50
Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances
TipRanks·11/13/2025 22:41
Scinai Immunotherapeutics Announces December 2025 Shareholder Meeting
TipRanks·11/13/2025 22:26
Scinai Immunotherapeutics Announces Board Changes and New Accounting Firm Amid Cost-Cutting Efforts
TipRanks·10/06/2025 12:20
Scinai Immunotherapeutics Secures Grant to Boost CDMO Capabilities
TipRanks·10/06/2025 11:40
Scinai Immunotherapeutics awarded grant from Israel Innovation Authority
Same Industry
Name/Symbol
Change%
Price